Locations:
Search IconSearch
February 2, 2026/Neurosciences/Podcast

The Past, Present and Future of DBS (Podcast)

Rapid innovation is shaping the deep brain stimulation landscape

Modern deep-brain stimulation (DBS), which dates back to the late 1990s, has become an important factor in the advancement of treatment of movement disorders such as Parkinson’s disease and essential tremor. As technology accelerates, however, DBS seems destined for ever more significant refinements and broader applications.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“DBS is a technology-driven, high science area, so it's rapidly progressing and somewhat unlimited,” says neurologist Benjamin Walter, MD, MBA. “The data that we're getting from the brain is fancy but fairly rudimentary still at this point. That's going to get a lot more complicated, where we can get different signals from different parts that may have different meaning.”

On an episode of the Neuro Pathways Podcast, Dr. Walter, medical director of Cleveland Clinic's Deep Brain Stimulation program, describes how DBS works and how it’s likely to improve.

“DBS is a pacemaker for the brain. It's very much like a cardiac pacemaker except that the wires go into the brain instead of into the heart,” Dr. Walter says. “The pacemaker itself is a battery in a computer that basically goes in the chest, very similar to cardiac pacemakers. DBS is able to adjustably control aberrant pathways and activities in the brain that are some of the underpinnings of movement disorders and tremors like Parkinson's disease, essential tremor and dystonia, and they are evolving to potentially be a treatment for other brain circuit disorders as well.”

The conversation also explores:

  • The history of the development of modern DBS
  • New and emerging applications for DBS, including obsessive-compulsive disorder, epilepsy, depression and stroke recovery
  • The use of imaging and real-time neural signals to place DBS leads with precision
  • Use of adaptive DBS to allow for stimulation adjustment based on real-time brain signals

Advertisement

Click the podcast player above to listen to the episode now, or read on for a short, edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Podcast excerpt

Podcast host Glen Stevens, DO, PhD: So my guess is you're pretty good at brain anatomy. The lesioning or the stimulation is based on where you assume something is anatomical, right?

Benjamin Walter, MD, MBA: That's correct. The MRI — which fortunately gives us a fairly fine resolution, the brain and these basal ganglia circuits — is a good first way of estimating where you want to stimulate, and you can find the structure on an MRI, but the MRI then has to be fused to a frame, which is attached to the patient's head in most cases. And usually a CAT scan is taken of that combined situation and those images are fused.

There's error sometimes in fusion, and that can cause [other] errors. And then when surgery takes place, the surgeon makes a bur hole and the CSF can leak out a little bit and there's always a little bit of brain shift. That will change the location of everything as well because it's based off the initial scans. But even if you're hitting the spot that looks right on the MRI, you're not necessarily in the right spot.

And so the real proof is what is there. What does it sound like? Can you pick up the neural activity of that region? And then even more so, test stimulation, either with a test probe or more importantly with the final DBS probe when you place it in there. Does it do what you expect it to do and what you want it to do? So that can be refined to microns in measurement to really get the right location and make sure that you're getting benefits without untoward side effects.

Advertisement

Dr. Stevens: So you're playing name that tune with the neurons?

Dr. Walter: Pretty much. It's like traveling through Europe and listening to different dialects of different languages and making sure that, first, you're in the right country and everybody's speaking Spanish in Spain, but then finding the right dialect for the city that you want to be in.

Advertisement

Related Articles

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

MRI of the brain against black background

Advanced Neuroimaging and Clinical Perseverance Make Sense of a 68-Year-Old’s Progressive Symptoms

A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief

brain scan with colored dots over a dark gray region
March 3, 2026/Neurosciences/Epilepsy

Decoding the Insula: New Semiological Insights for Localizing Seizure Onset

Guidance from the largest cohort of SEEG-confirmed insular epilepsy patients reported to date

Photo of Dr. Ford
March 2, 2026/Neurosciences/Podcast

Neuroethics Conversations: Guidelines for Care (Podcast)

Ethical guidance provides guardrails so medical advances benefit patients

red blood cells floating in a blood vessel
February 27, 2026/Neurosciences/Cerebrovascular

Factor XIa Inhibition Drives Down Recurrent Stroke Risk Without Rise in Bleeding

OCEANIC-STROKE results represent long-sought advance in secondary stroke prevention

two brightly colored brain scans side by side
February 25, 2026/Neurosciences/Epilepsy

MR Fingerprinting Shows Potential to Reshape FCD Detection and Epileptogenicity Mapping

Two studies from Cleveland Clinic may help advance the technology toward broader clinical use

MRI scan of the side of a human head
February 20, 2026/Neurosciences/Cerebrovascular

Susac Syndrome: Insights on Rare Endotheliopathy From Largest Single-Center Cohort to Date

Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss

Ad